Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literature

Published:2022-08 Issue:4 Volume:46 Page:100863
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

He Xing,Tu Rongfang,Zeng Saili,He Zhenhua,Liu Sha^ORCID,Fang Yong

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Management of immune related adverse events induced by immune checkpoint inhibition;Teufel;Cancer Lett,2019

2. Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody;Matsuoka;BMC Cancer,2020

3. Non-bacterial cystitis with increased expression of programmed death-ligand 1 in the urothelium: An unusual immune-related adverse event during treatment with pembrolizumab for lung adenocarcinoma;Ueki;IJU Case Rep,2020

4. A case of cystitis after administration of nivolumab;Ozaki;Intl Cancer Conf J,2017

5. Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor;Shimatani;Urol Case Rep,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case reports of immune-related cystitis and the antibody combination hypothesis;Immunotherapy;2024-09-12

2. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

3. Drug-Related Cystitis: An Overview;Cystitis - Updates and Challenges;2023-10-11

4. Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature;Frontiers in Immunology;2023-10-06

5. Recurrent Cystitis Associated With 2 Programmed Death 1 Inhibitors;Journal of Immunotherapy;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3